The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer

被引：0
|
作者：
Mehmet Erdogan
Sevim S. Sengul
Bulent Cetin
Mustafa Avcı
Samet Yagci
Ismail Ozkoç
Damla Ezgi Barikan
Mustafa Yildiz
机构：
[1] Suleyman Demirel University Faculty of Medicine,Department of Nuclear Medicine
[2] Suleyman Demirel University Faculty of Medicine,Division of Medical Oncology, Department of Internal Medicine
来源：
Annals of Nuclear Medicine | 2022年 / 36卷
关键词：
Lutetium-177 PSMA; Gallium-68 PSMA; Metastatic castration resistant prostate cancer; TL PSMA; PSMA TV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：562 / 569
页数：7
相关论文
共 50 条
  • [21] Comparison of 68Ga-PSMA and 177Lu-PSMA Total Metabolic Tumor Volume (TMTV) variations for monitoring metastatic castration-resistant prostate cancer in 177Lu-PSMA therapy.
    Boursier, C.
    Zaragori, T.
    Kunsch, J.
    Olivier, P.
    Claudin, M.
    Marie, P.
    Bros, M.
    Bordonne, M.
    Verger, A.
    Karcher, G.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S362
  • [22] Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CT
    Roll, Wolfgang
    Bode, Axel
    Weckesser, Matthias
    Boegemann, Martin
    Rahbar, Kambiz
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (02) : 152 - 153
  • [23] Castration-Resistant Prostate Cancer Patterns of Metastasis Evaluated by 68Ga-PSMA PET/CT
    Silva, M.
    Silva, R.
    Lapa, P.
    Costa, G.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S721 - S721
  • [24] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Jianpeng Cao
    Yue Chen
    Mei Hu
    Wei Zhang
    Annals of Nuclear Medicine, 2021, 35 : 861 - 870
  • [25] 177Lu-PSMA-RLT of metastatic castration-resistant prostate cancer: limitations and improvements
    Cao, Jianpeng
    Chen, Yue
    Hu, Mei
    Zhang, Wei
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (08) : 861 - 870
  • [26] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [27] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [28] High Activity 177Lu-PSMA Therapy Of Metastatic Castration-resistant Prostate Cancer
    Happel, C.
    Kranert, W. T.
    Bockisch, B.
    Groener, D.
    Davis, K. H.
    Wichert, J.
    Stefanova, M.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S647 - S648
  • [29] The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA
    Oflas, M.
    Simsek, D. Has
    Sanli, Y.
    Kuyumcu, S.
    Isik, E.
    Karadogan, S.
    Basaran, M.
    Ekenel, M.
    Mudun, A.
    Ozkan, Z. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S649 - S650
  • [30] 68Ga-FAPI-46 PET/CT in a Metastatic Castration-Resistant Prostate Cancer Patient With Low PSMA Expression
    Aryana, Kamran
    Manafi-Farid, Reyhaneh
    Amini, Hamidreza
    Divband, Ghasemali
    Moghadam, Soroush Zarehparvar
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : 972 - 973
12345